Primary Blepharospasm: Diagnosis and Management

Drugs

Volumn 64, Issue 3, 2004, Pages 237-244

  Defazio, Giovanni ^a   Livrea, Paolo ^a  

^a UNIVERSITY OF BARI   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

BENZODIAZEPINE DERIVATIVE; BOTULINUM TOXIN A; BOTULINUM TOXIN B; CLONAZEPAM; DOPAMINE RECEPTOR STIMULATING AGENT; DOXORUBICIN; NEUROBLOCK; NEUROLEPTIC AGENT; NICOTINE; TRIHEXYPHENIDYL;

APRAXIA; BLEPHAROSPASM; CLINICAL FEATURE; CLINICAL TRIAL; CONFUSION; DIFFERENTIAL DIAGNOSIS; DIPLOPIA; DISABILITY; DISEASE COURSE; DYSTONIA; EYELID; FACE; FACIAL NERVE PARALYSIS; HALLUCINATION; HUMAN; JAW; MEMORY DISORDER; MOTOR DYSFUNCTION; MUSCLE CONTRACTION; NECK MUSCLE; ORBICULARIS OCULI MUSCLE; PATHOPHYSIOLOGY; PATIENT; PTOSIS; REVIEW; SIDE EFFECT; SKIN IRRITATION; SYMPTOM; TREATMENT INDICATION; VISUAL IMPAIRMENT;

BLEPHAROSPASM; BOTULINUM TOXIN TYPE A; DIAGNOSIS, DIFFERENTIAL; HUMANS;

EID: 1442284258     PISSN: 00126667     EISSN: None     Source Type: Journal    
DOI: 10.2165/00003495-200464030-00002     Document Type: Review

References (59)

1. Fahn S, Bressman SB, Marsden CD. Classification of dystonia. In: Fahn S, Marsden CD, DeLong MR, editors. Dystonia 3: advances in neurology. Philadelphia (PA): Lippincott-Raven, 1998: 121-6
2. Jankovic J, Ford J. Blepharospasm and orofacial-cervical dystonia: clinical and pharmacological findings in 100 patients. Ann Neurol 1988; 13: 402-11
3. Grandas F, Elston J, Quinn N, et al. Blepharospasm: a review of 264 patients. J Neurol Neurosurg Psychiatry 1988; 51: 767-72
4. Salorio PD, Conte RQ. Ophthalmologic causes of blepharospasm. In: Jankovic J, Tolosa E, editors. Advances in neurology. New York: Raven Press 1988: 91-102
5. Defazio G, Brancati F, Valente EM, et al. Familial blepharospasm is inherited as an autosomal dominant trait and relates to a novel unassigned gene. Mov Disord 2003; 18: 207-12
6. Defazio G, Berardelli A, Abbruzzese G, et al. Possible risk factors for primary adult-onset dystonia: a case-control investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry 1998; 64: 25-32
7. Defazio G, Livrea P. Epidemiology of primary blepharospasm. Mov Disord 2002; 17 (1): 7-12
8. Muller J, Kiechl S, Wenning GK, et al. The prevalence of primary dystonia in the general community. Neurology 2002; 59: 941-3
9. Logroscino G, Livrea P, Anaclerio D, et al. Agreement among neurologists on the clinical diagnosis of dystonia at different body sites. J Neurol Neurosurg Psychiatry 2003; 74 (3): 348-50
10. Aramideh M, Ongerboer de Visser BW, Devriese BB, et al. Electromyographic features of levator palpebrae superioris and orbicularis oculi muscles in blepharospasm. Brain 1994; 117: 27-38
11. Porter JD, Burns LA, May PJ. Morphological substrate for eyelid movements: innervation and structure of primate levator palpebrae superioris and orbicularis oculi muscles. J Comp Neurol 1989; 287: 64-81
12. Elston JS. A new variant of blepharospasm. J Neurol Neurosurg Psychiatry 1992; 55: 369-71
13. Aramideh M, Koelman JH, Speelman JD, et al. Eyelid movement disorders and electromyography. Lancet 2001; 357: 805-6
14. Boghen D. Apraxia of eyelid opening. Neurology 1985; 35: 423-7
15. Fahn S. Blepharospasm: a form of focal dystonia. In: Jankovic J, Tolosa E, editors. Advances in neurology. New York: Raven Press, 1988: 125-33
16. Sforza EA, Montagna P, Defazio G, et al. Sleep and cranial dystonia. Electroencephalogr Clin Neurophysiol 1991; 79: 166-9
17. Gomez-Wong E, Marti MJ, Cossu G, et al. The 'geste antagonistique' induces transient modulation of the blink reflex in human patients with blepharospasm. Neurosci Lett 1998; 251: 125-8
18. Elston JS, Marsden CD, Grandas F, et al. The significance of ophthalmological symptoms in idiopathic blepharospasm. Eye 1988; 2: 435-9
19. Greene P, Kang UJ, Fahn S. Spread of symptoms in idiopathic torsion dystonia. Mov Disord 1995; 10: 143-52
20. Defazio G, Berardelli A, Abbruzzese G, et al. Risk factors for spread of primary adult-onset blepharospasm: a multicentre investigation by the Italian Movement Disorders Study Group. J Neurol Neurosurg Psychiatry 1999; 67: 613-9
21. Jankovic J. Etiology and differential diagnosis of blepharospasm. In: Jankovic J, Tolosa E, editors. Advances in neurology. New York: Raven Press, 1988: 103-16
22. Digre K, Corbett JJ. Hemifacial spasm: differential diagnosis, mechanism and treatment. In: Jankovic J, Tolosa E, editors. Advances in neurology. New York: Raven Press, 1988: 151-76
23. Tseng SCG, Tsubota K. Important concepts for treating ocular surface and tear disorders. Am J Opthalmol 1997; 124: 825-35
24. Bressamn SB. Dystonia update. Clin Neuropharmacol 2000; 23: 239-51
25. Calne DB, Lang AE. Secondary dystonia. In: Fahn S, Marsden CD, DeLong MR, editors. Dystonia 3: advances in neurology. Philadelphia (PA): Lippincott-Raven, 1998: 9-33
26. Sachdev P. Tardive blepharospasm. Mov Disord 1998; 13: 947-51
27. Marsden CD. The problem of adult-onset idiopathic torsion dystonia and other isolated dyskinesias in adult life (including blepharospasm, oromandibular dystonia, dystonic writer's cramp, and torticollis or axial dystonia). In: Eldridge R, Fahn S, editors. Advances in neurology. New York: Raven Press, 1976: 1-10
28. Fahn S, Williams DT. Psychogenic dystonia. In: Fahn S, Marsden CD, DeLong MR, editors. Dystonia 3: advances in neurology. Philadelphia (PA): Lippincott-Raven, 1998: 431-55
29. American Academy of Neurology Assessment. The clinical usefulness botulinum toxin A in treating neuralgic disorders: report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology. Neurology 1990; 40: 1332-6
30. American Academy of Ophthalmology. Botulinum toxin therapy of eye muscle disorders: safety and effectiveness. Ophthalmology 1989; 96 Pt 2: 37-41
31. Jankovic J, Oman J. Botulinum A toxin for cranial cervical dystonia: a double-blind placebo-controlled study. Neurology 1987; 37: 616-23
32. Jost WH, Kohl A. Botulinum toxin: evidence-based medicine in blepharospasm and hemifacial spasm. J Neurol 2001; 248 Suppl. 1: 21-4
33. Aramideh M, Ongerboer de Visser BW, Brans JMW, et al. Pretarsal application of botulinum toxin for treatment of blepharospasm. J Neurol Neurosurg Psychiatry 1995; 59: 309-11
34. Forget R, Tozlovanu V, Iancu A, et al. Botulinum toxin improves lid opening delays in blepharospasm-associated apraxia of eyelid opening. Neurology 2002; 58: 1843-6
35. Borodic GE, Ferrante R, Pearce LB, et al. Histologic assessment of dose-related diffusion and muscle fiber response after therapeutic botulinum toxin injection. Mov Disord 1994; 9: 31-9
36. Van den Bergh PYK, Lison DF. Dose standardization of botulinum toxin. In: Fahn S, Marsden CD, DeLong M, editors. Dystonia 3: advances in neurology. Philadelphia (PA): Lippincott-Raven Publishers, 1998: 231-5
37. Lindeboom R, De Haan R, Aramideh M, et al. The blepharospasm disability scale: an instrument for the assessment of functional health in blepharospasm. Mov Disord 1995; 10: 444-9
38. Horwath-Winter J, Berglorff J, Floegel I, et al. Botulinum toxin A treatment in patients suffering from blepharospasm and dry eye. Br J Opthalmol 2003; 87: 54-6
39. Drummond GT, Hinz BJ. Botulinum toxin for blepharospasm and hemifacial spasm: stability of duration of effect and dosage over time. Can J Opthalmol 2001; 36: 398-403
40. Calace P, Cortese G, Piscopo R, et al. treatment of blepharospasm with botulinum neurotoxin type A: long-term results. Eur J Opthalmol 2003; 13: 331-6
41. Kowal L. Pretarsal injections of botulinum toxin improve blepharospasm in previously unresponsive patients [letter]. J Neurol Neurosurg Psychiatry 1997; 63: 556
42. Greene P, Fahn S, Diamond B. Development of resistance to botulinum toxin A in patients with torticollis. Mov Disord 1994; 9: 213-7
43. Jankovic J, Schwartz K. Response and immunoresistance to botulinum toxin injections. Neurology 1995; 45: 1743-6
44. Dressler D. Complete secondary botulinum toxin therapy failure in blepharospasm. J Neurol 2000; 247: 809-10
45. Racette BA, Stambuk M, Perlmutter JS. Secondary nonresponsiveness to new bulk botulinum toxin A (BCB2024). Mov Disord 2002; 17: 1098-100
46. Rollnik JD, Wohlfarth K, Dengler R, et al. Neutralizing botulinum toxin type A antibodies: clinical observations in patients with cervical dystonia. Neurol Clin Neurophysiol 2001; 2001 (3): 2-4
47. Colosimo C, Chianese M, Giovannelli M, et al. Botulinum toxin type B in blepharospasm and hemifacial spasm. J Neuroophthalmol 2003; 23: 11-5
48. Cakmur R, Ozturk V, Uzunel F, et al. Comparison of preseptal and pretarsal injections of botulinum toxin in the treatment of blepharospasm and hemifacial spasm. J Neurol 2002; 249 (1): 64-8
49. Wutthiphan S, Kowal I, O'Day J, et al. Diplopia following subcutaneous injections of botulinum A toxin for facial spasms. J Pediatr Ophthalmol Strabismus 1997; 34: 229-3
50. Hallett M. Blepharospasm: recent advances. Neurology 2002; 59: 1306-132
51. Zudas A, Cianchetti C. Efficacy of risperidone in idiopathic segmental dystonia. Lancet 1996; 347: 127-8
52. Tolosa ES, Lai C. Meige disease: striatal dopaminergic preponderance. Neurology 1979; 29: 1126-30
53. Greene P, Shale H, Fahn S. Analysis of open label trial in torsion dystonia using high dose of anticholinergics and other drugs. Mov Disord 1988; 3: 46-60
54. Jankovic J. Medical therapy and botulinum toxin in dystonia: classification of dystonia. In: Fahn S, Marsden CD, DeLong MR, editors. Dystonia 3: advances in neurology. Philadelphia (PA): Lippincott-Raven, 1998: 169-83
55. Nutt JG, Hammerstad JP, deGarmo P, et al. Cranial dystonia: double-blind crossover study with anticholinergics. Neurology 1984; 34: 215-7
56. Dursun SM, Hewitt S, King AL, et al. Treatment of blepharospasm with nicotine nasal spray [letter]. Lancet 1996 Jul 6; 348 (9019): 60
57. Dressler D, Scaravilli T, Bhatia KP, et al. Nicotine nasal spray is not reliable treatment for blepharospasm: results of a pilot study. Mov Disord 1998; 13: 190
58. Wirtschafter JD, McLoon LK. Long term efficacy of local doxorubicin chemomyectomy in patients with blepharospasm ad hemifacial spasm. Ophthalmology 1998; 105: 342-6
59. Anderson RL, Patel BC, Holds JB, et al. Blepharospasm: past, present, and future. Ophthal Plast Reconstr Surg 1998; 14: 305-17